MoneyWorks4Me

Ajanta Pharma - Quaterly Results

03 Nov 2022 Evaluate
The quarter ended September 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 8372.30 millions.The Net Profit of the company registered a slight decline of -15.07% to Rs. 1671.80  millions from Rs. 1968.50 millions.Operating Profit reported a sharp decline to 2391.00 millions from 2852.60 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 8372.30 8237.10 1.64 16875.20 15664.30 7.73 31406.40 27185.90 15.52
Other Income 783.70 524.10 49.53 1137.90 834.10 36.42 1397.30 1035.70 34.91
PBIDT 2391.00 2852.60 -16.18 4608.30 5492.80 -16.10 10306.20 10204.80 0.99
Interest 7.10 0.70 914.29 13.40 12.40 8.06 91.20 69.00 32.17
PBDT 2383.90 2851.90 -16.41 4594.90 5480.40 -16.16 10215.00 10135.80 0.78
Depreciation 318.00 304.00 4.61 625.50 601.60 3.97 1209.60 1114.90 8.49
PBT 2065.90 2547.90 -18.92 3969.40 4878.80 -18.64 9005.40 9020.90 -0.17
TAX 394.10 579.40 -31.98 793.90 975.70 -18.63 1806.80 2264.50 -20.21
Deferred Tax -61.10 30.80 -298.38 -79.40 63.40 -225.24 95.10 97.70 -2.66
PAT 1671.80 1968.50 -15.07 3175.50 3903.10 -18.64 7198.60 6756.40 6.54
Equity 257.10 173.90 47.84 257.10 173.90 47.84 171.70 173.90 -1.27
PBIDTM(%) 28.56 34.63 -17.54 27.31 35.07 -22.12 32.82 37.54 -12.58
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..